| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
orig3n [2022/12/04 17:17] pamela [Collecting DNA Selling Hope] | orig3n [2023/01/12 23:30] (current) liam |
|---|
| ===== Orig3n Inc ===== | ====== Orig3n ====== |
| {{::orig3n_logo.png?200 |}} | |
| | {{ ::orig3n_logo.png?200|}} |
| ==== History ==== | ==== History ==== |
| |
| Smith, who has a background in scientific data management, has poured money into high-profile sponsorships and marketing events, setting up a demo test center where the 49ers play and becoming a headlining sponsor of San Francisco’s annual Bay to Breakers footrace. ((https://web.archive.org/web/20190911221532/https://www.bloomberg.com/news/articles/2019-09-11/dna-company-orig3n-tampered-with-results-former-employees-say)) | Smith, who has a background in scientific data management, has poured money into high-profile sponsorships and marketing events, setting up a demo test center where the 49ers play and becoming a headlining sponsor of San Francisco’s annual Bay to Breakers footrace. ((https://web.archive.org/web/20190911221532/https://www.bloomberg.com/news/articles/2019-09-11/dna-company-orig3n-tampered-with-results-former-employees-say)) |
| |
| === Officers/Directors === | ==== Leadership Team ==== |
| | |
| | ((https://web.archive.org/web/20151025003932/http://www.orig3n.com/team/)) |
| | {{ ::origi3ns_leadership_team.png?600|}} |
| |
| [[:Rene Oda]] - Director Product Management, Orig3n Inc ((https://www.bloomberg.com/profile/person/20428301?leadSource=uverify%20wall)) | [[:Rene Oda]] - Director Product Management, Orig3n Inc ((https://www.bloomberg.com/profile/person/20428301?leadSource=uverify%20wall)) |
| |
| [[:James Lovgren]] - Chief Business Officer | [[:James Lovgren]] - Chief Business Officer |
| | James Lovgren has a track record of commercializing disruptive technologies and managing global product portfolios in excess of $70MM. James joined ORIG3N from [[:Life Technologies]] (Thermo Fisher Scientific), where he built a robust stem cell portfolio and managed the **most successful [[:transfection]] product launch in corporate history**. He holds a BS in Biology from the [[:University of North Florida]] and an MBA from [[:North Carolina State University]]. |
| |
| [[:Jamie Metzl]] - Chief Strategy Officer | [[:Jamie Metzl]] - Chief Strategy Officer |
| | Jamie Metzl brings a wealth of experiences to ORIG3N. He was a partner in the global investment firm [[:Cranemere]], and has served on the U.S. Senate Foreign Relations Committee, the [[:State Department]], & the [[:National Security Council]]. His books include the novel Genesis Code, which deals with issues around human genetic enhancement. He holds a PhD from Oxford, a JD from Harvard Law School, and a BA from Brown University. |
| | |
| | [[:Marcie Glicksman]] PhD CSO Consultant |
| | Dr. Marcie Glicksman has been in the drug discovery field for over 20 years, and has extensive experience in assay development, **high throughput screening, and chemical databases**. Before joining ORIG3N, she was **Co-Director** of the Laboratory for Drug Discovery in Neurodegeneration (LDDN), part of the [[:Harvard]] NeuroDiscovery Center. She holds a BA from Brown University and a PhD in Neuroscience from [[:Washington University]]. |
| | |
| | [[:Michael Fang]], MD, Chief Medical Officer |
| | Michael Fang is a physician and entrepreneur with a dual specialty in Internal Medicine and Geriatric Medicine. A founder of [[:CETA]], a **health information technology company**, he led the company in 1,500% growth over 3 years. In 2015, CETA ranked #297 on Inc. Magazine’s 5000 fastest-growing private US companies. Formerly, Michael co-founded [[:IMOSPHERE]], Inc. He holds a BA and a medical degree, both from Northwestern University. |
| | |
| | [[:Ken Levine]] VP Human Resources |
| | |
| | [[:Jish Mukerji]] |
| | Jish Mukerji comes to ORIG3N with over 15 years of experience in consumer marketing. For 9 of those years, Jish worked at [[:Apple]] as **Senior Marketing Manager for iPhone and iPad,** developing content strategies for national and international markets. Jish also has extensive product management experience in life sciences, and has worked in life science research and clinical diagnostics. He holds an MS from McGill University. |
| | |
| | [[:Shadrack Frazier]] VP Engineering ((https://web.archive.org/web/20210125212806/https://craft.co/orig3n/executives)) |
| | |
| | ==== Honors ==== |
| |
| === Honors === | |
| {{ ::orig3n_co-founders_robin_smith_and_kate_blanchard.png?400|}} | {{ ::orig3n_co-founders_robin_smith_and_kate_blanchard.png?400|}} |
| Our founders, Robin Y Smith, CEO and Kate Blanchard, COO were recently announced as Finalists in the **Ernst and Young Entrepreneur of the Year 2018 New England Awards** program. As the world’s most prestigious business award for entrepreneurs, we are so proud to be recognized as a leader at the forefront of the biotech industry. | Our founders, [[:Robin Y Smith]], CEO and [[:Kate Blanchard]], COO were recently announced as Finalists in the **Ernst and Young Entrepreneur of the Year 2018 New England Awards** program. As the world’s most prestigious business award for entrepreneurs, we are so proud to be recognized as a leader at the forefront of the biotech industry. |
| |
| Orig3n co-founders, Robin Smith and Kate Blanchard, bring a combined 35 plus years of experience to the groundbreaking regenerative medicine and consumer genetics industries. After previously working together for three years at Perkin Elmer after it acquired their last startup, [[:ArtusLabs]], Robin and Kate formed a remarkable partnership that is marked by ambition and dedication to social good.((https://web.archive.org/web/20210925021854/https://www.teloyears.com/blog/ey-blog-draft/)) | Orig3n co-founders, Robin Smith and Kate Blanchard, bring a combined 35 plus years of experience to the groundbreaking regenerative medicine and consumer genetics industries. After previously working together for three years at Perkin Elmer after it acquired their last startup, [[:ArtusLabs]], Robin and Kate formed a remarkable partnership that is marked by ambition and dedication to social good.((https://web.archive.org/web/20210925021854/https://www.teloyears.com/blog/ey-blog-draft/)) |
| ORIG3N is a biotechnology company, collects DNA samples and researches and develops treatments for genetically inherited diseases. | ORIG3N is a biotechnology company, collects DNA samples and researches and develops treatments for genetically inherited diseases. |
| |
| Orig3n **helps people understand the links between their genes and how their minds and bodies work.** The company operates an online application for selling DNA test kits, collecting genetic samples for the research and development, and provides DNA results. | Orig3n **helps people understand the links between their genes and how their minds and bodies work.** The company operates an online application for selling [[:DNA test kits]], **collecting genetic samples** for the research and development, and provides DNA results. |
| |
| |
| ORIG3N product portfolio includes LifeProfiles, a series of genetic tests comprising FITCODE that provides reports and insights on various aspects of fitness, including metabolism, muscle strength, endurance, joints, power performance, and exercise recovery; and AURA for assessment and insight on various aspects of skin, as well as Life Capsule, a blood cell repository for regenerative medicine development. | ORIG3N product portfolio includes [[:LifeProfiles]], a series of genetic tests comprising FITCODE that provides reports and insights on various aspects of fitness, including metabolism, muscle strength, endurance, joints, power performance, and exercise recovery; and AURA for assessment and insight on various aspects of skin, as well as Life Capsule, a blood cell repository for regenerative medicine development. |
| |
| ORIG3N's investors include Haitong International Securities Group Vectr Ventures, Spectrum Health Ventures etc. The company has acquired Interleukin Genetics in Nov 22, 2017 to date. ((https://web.archive.org/web/20210928042400/https://paganresearch.io/company/orig3n)) | ORIG3N's investors include [[:Haitong International Securities Group Vectr Ventures]], [[:Spectrum Health Ventures]] etc. The company has acquired [[:Interleukin Genetics]] in Nov 22, 2017 to date. ((https://web.archive.org/web/20210928042400/https://paganresearch.io/company/orig3n)) |
| |
| |